featured
VP-102, a Drug–Device Combination Product Containing Cantharidin 0.7% (w/v), for the Treatment of Molluscum Contagiosum
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Journal of Clinical Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum
Am J Clin Dermatol 2021 Feb 18;[EPub Ahead of Print], LF Eichenfield, E Siegfried, P Kwong, M McBride, J Rieger, D Glover, C Willson, M Davidson, P Burnett, M OlivadotiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.